Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
BONESUPPORT HOLDING AB ( (SE:BONEX) ) has issued an announcement.
BONESUPPORT announces a leadership transition with Emil Billbäck stepping down as CEO to become a Senior Advisor, while Torbjörn Sköld will take over as CEO starting September 1, 2025. This change is expected to leverage Sköld’s extensive MedTech experience to further elevate the company’s position in the orthobiologics market. The board acknowledges Billbäck’s contributions in transforming BONESUPPORT into a profitable and fast-growing entity. Sköld is enthusiastic about continuing the company’s mission of transforming outdated care standards with innovative solutions.
More about BONESUPPORT HOLDING AB
BONESUPPORT is a leading company in the orthobiologics industry, specializing in the development and commercialization of innovative injectable bio-ceramic bone graft substitutes. These products are designed to remodel into the patient’s own bone and have drug-eluting capabilities. The company is based in Lund, Sweden, and has shown significant growth with net sales reaching SEK 899 million in 2024.
YTD Price Performance: -20.24%
Average Trading Volume: 361
Technical Sentiment Signal: Sell
Current Market Cap: $2.16B
See more insights into BONEX stock on TipRanks’ Stock Analysis page.